Item 5. Market for Registrant’s Common Equity
ITEM 5. MARKET FOR REGISTRANT’S COMMON
EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
Market Information
On July 13, 2021, our common stock began trading
on The Nasdaq Capital Market under the symbol “UNCY.” Prior to that time, there was no public market for our common stock.
Stockholders
As of March 28, 2025, there were 99 stockholders
of record of our common stock. The actual number of holders of our common stock is greater than this number of record holders, and includes
stockholders who are beneficial owners, but whose shares are held in street name by brokers or held by other nominees. This number of
holders of record also does not include stockholders whose shares may be held in trust by other entities.
Dividend Policy
We currently anticipate that we will retain future
earnings for the development, operation and expansion of our business and do not anticipate declaring or paying any cash dividends for
the foreseeable future, except that in March 2023,we agreed with certain investors to modify our dividend policy to state that we intend
to pay dividends to all stockholders on a quarterly basis in an amount of which the aggregate of all quarterly dividends shall equal at
least seventy-five percent (75%) of our annual net cash flow from operations following the approval of Oxylanthanum Carbonate by the FDA
if obtained, and the commencement of commercial sales.
Recent Sales of Unregistered Securities
None.
Issuers Purchases
of Equity Securities
None.
ITEM 6. [RESERVED]
- 68 -
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.